Ruffer’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.48M Buy
68,039
+33,498
+97% +$5.38M 0.28% 92
2026
Q2
$5.81M Sell
34,541
-1,592
-4% -$236K 0.21% 92
2026
Q1
$4.77M Buy
36,133
+18,680
+107% +$2.48M 0.2% 69
2025
Q4
$2.48M Buy
+17,453
New +$2.53M 0.11% 118

Other funds holding NBIX

Ruffer's NBIX Position: Q3 2026 in Review

Ruffer increased its Neurocrine Biosciences (NBIX) stake by 97% in Q3 2026, buying an estimated $5.38M and bringing the position to 68,039 shares worth $5.48M. The position accounts for 0.28% of the portfolio, ranked #92.

Ruffer first reported a position in NBIX in Q4 2025 and has held it in 4 quarters since. The position peaked at $5.81M in Q2 2026. 630 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.

  • Ruffer held 68,039 shares of Neurocrine Biosciences worth $5.48M as of Q3 2026.
  • Ruffer bought 33,498 Neurocrine Biosciences shares in Q3 2026, an estimated $5.38M.
  • Neurocrine Biosciences made up 0.28% of Ruffer's portfolio in Q3 2026, its #92 holding.
  • Ruffer first reported a position in Neurocrine Biosciences in Q4 2025 and has held it in 4 quarters since.
  • Ruffer's Neurocrine Biosciences position peaked at $5.81M in Q2 2026.
  • 630 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.

Based on Ruffer's 13F filing for Q3 2026, filed 10 Nov 2026.